AMERIPRISE FINANCIAL INC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$54,792
-82.7%
38,050
-70.1%
0.00%
Q2 2023$317,187
-21.0%
127,384
-15.0%
0.00%
Q1 2023$401,477
-36.5%
149,805
+28.7%
0.00%
Q4 2022$632,000
-56.9%
116,410
-1.0%
0.00%
-100.0%
Q3 2022$1,468,000
+163.6%
117,589
+4.3%
0.00%
Q2 2022$557,000
-32.3%
112,723
+4.1%
0.00%
Q1 2022$823,000
-19.7%
108,301
+7.8%
0.00%
Q4 2021$1,025,000
-37.6%
100,451
-18.0%
0.00%
-100.0%
Q3 2021$1,643,000
-35.2%
122,447
+5.9%
0.00%0.0%
Q2 2021$2,537,000
+43.7%
115,651
+57.6%
0.00%0.0%
Q1 2021$1,765,000
+9.4%
73,363
-18.2%
0.00%0.0%
Q4 2020$1,614,000
+94.0%
89,699
+24.6%
0.00%
Q3 2020$832,000
-56.6%
72,005
-8.8%
0.00%
-100.0%
Q2 2020$1,915,000
+96.2%
78,957
-10.8%
0.00%0.0%
Q1 2020$976,000
-53.5%
88,521
+11.5%
0.00%0.0%
Q4 2019$2,098,000
+35.3%
79,411
+16.6%
0.00%0.0%
Q3 2019$1,551,000
-34.3%
68,099
-11.5%
0.00%0.0%
Q2 2019$2,360,000
+131.6%
76,962
+25.3%
0.00%
Q1 2019$1,019,000
+55.8%
61,400
+79.9%
0.00%
Q4 2018$654,000
-42.6%
34,122
+10.9%
0.00%
-100.0%
Q1 2018$1,140,00030,7690.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders